MORGAN LEWIS: Open Payments
NPI 1851067870 · ROCKINGHAM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| Janssen Biotech, Inc. | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: SKYRIZI, TREMFYA, Zoryve, NEMLUVIO, DUPIXENT, OTEZLA, Winlevi, COSENTYX.
Industry payments across VA — which companies pay providers there.
